NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE

NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE was reported 2597 times

NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 VULVOVAGINITIS ALLERGIC 2 0.2857
1 ANTERIOR CHAMBER ANGLE NEOVASCULARISATION 1 0.2000
2 CONFLUENT AND RETICULATE PAPILLOMATOSIS 1 0.0833
3 CATATHRENIA 1 0.0769
4 ANKLE IMPINGEMENT 1 0.0333
5 LARYNGITIS FUNGAL 3 0.0233
6 EXPOSURE TO ALLERGEN 7 0.0219
7 COLPOSCOPY 1 0.0179
8 CLAUDICATION OF JAW MUSCLES 1 0.0167
9 ADJUSTMENT DISORDER WITH ANXIETY 1 0.0147
10 AUTOINFLAMMATORY DISEASE 3 0.0142
11 COELIAC ARTERY COMPRESSION SYNDROME 1 0.0133
12 BRONCHIAL OEDEMA 1 0.0106
13 COMPULSIVE LIP BITING 1 0.0096
14 ADMINISTRATION SITE HAEMORRHAGE 1 0.0096
15 PERIORBITAL HAEMORRHAGE 2 0.0092
16 AUTOIMMUNE THYROID DISORDER 1 0.0092
17 BLOOD GROWTH HORMONE ABNORMAL 1 0.0082
18 BODY MASS INDEX ABNORMAL 2 0.0082
19 CHEMICAL BURN OF GENITALIA 1 0.0082
20 DELAYED PUBERTY 2 0.0079
21 CERVICOGENIC HEADACHE 1 0.0074
22 CERVIX CARCINOMA STAGE 0 2 0.0070
23 ACOUSTIC STIMULATION TESTS ABNORMAL 1 0.0064
24 CHONDRITIS 1 0.0057
25 TRANSVERSE SINUS THROMBOSIS 3 0.0057
26 BLOOD COPPER INCREASED 1 0.0056
27 ARM AMPUTATION 1 0.0055
28 ACANTHOSIS NIGRICANS 1 0.0054
29 POLYCYSTIC OVARIAN SYNDROME 2 0.0052
30 ANOVULATORY CYCLE 1 0.0048
31 ANTIDEPRESSANT DISCONTINUATION SYNDROME 1 0.0048
32 STATUS ASTHMATICUS 2 0.0042
33 ARRESTED LABOUR 1 0.0042
34 IMMUNODEFICIENCY COMMON VARIABLE 2 0.0041
35 BLOOD LUTEINISING HORMONE INCREASED 1 0.0041
36 ADENOTONSILLECTOMY 1 0.0040
37 CAVERNOUS SINUS THROMBOSIS 1 0.0039
38 INTRACRANIAL VENOUS SINUS THROMBOSIS 4 0.0037
39 CATHETER SITE THROMBOSIS 1 0.0036
40 DEJA VU 1 0.0036
41 BILIARY DYSKINESIA 6 0.0035
42 GALLBLADDER NON-FUNCTIONING 2 0.0035
43 GLUTEN SENSITIVITY 5 0.0035
44 LIP PRURITUS 3 0.0035
45 SALPINGECTOMY 2 0.0035
46 BLOOD 25-HYDROXYCHOLECALCIFEROL DECREASED 1 0.0034
47 BURSA DISORDER 1 0.0034
48 ALLERGY TO METALS 2 0.0033
49 ADMINISTRATION SITE SWELLING 1 0.0031
50 CATHETER SITE IRRITATION 1 0.0030
51 AUTONOMIC NEUROPATHY 3 0.0030
52 GENITAL SWELLING 2 0.0029
53 RETINAL VEIN THROMBOSIS 2 0.0029
54 BLOOD OESTROGEN DECREASED 2 0.0028
55 FACIAL DISCOMFORT 2 0.0028
56 BIPOLAR II DISORDER 1 0.0028
57 WITHDRAWAL BLEED 2 0.0027
58 AXILLARY VEIN THROMBOSIS 1 0.0027
59 COELIAC DISEASE 26 0.0026
60 NARCOLEPSY 5 0.0026
61 GALLBLADDER POLYP 2 0.0025
62 RETINAL PIGMENTATION 2 0.0025
63 CHOLECYSTITIS CHRONIC 17 0.0025
64 CLUBBING 1 0.0025
65 MENSTRUAL DISORDER 20 0.0024
66 PRE-EXISTING CONDITION IMPROVED 15 0.0024
67 INTERMENSTRUAL BLEEDING 13 0.0023
68 POLYMENORRHOEA 8 0.0023
69 PREGNANCY ON ORAL CONTRACEPTIVE 6 0.0023
70 ABNORMAL SLEEP-RELATED EVENT 3 0.0023
71 JAW OPERATION 2 0.0022
72 ABULIA 2 0.0022
73 CHLOASMA 1 0.0022
74 CATAPLEXY 3 0.0021
75 METRORRHAGIA 35 0.0021
76 ARTIFICIAL CROWN PROCEDURE 1 0.0020
77 ALLERGIC REACTION TO EXCIPIENT 4 0.0020
78 THROMBOPHLEBITIS SUPERFICIAL 6 0.0020
79 PRODUCT ADMINISTRATION INTERRUPTED 15 0.0019
80 ALLERGY TO ANIMAL 2 0.0019
81 ESSENTIAL TREMOR 2 0.0018
82 COLECTOMY TOTAL 1 0.0018
83 COLONIC FISTULA 1 0.0018
84 DYSMENORRHOEA 23 0.0017
85 ANTIPHOSPHOLIPID ANTIBODIES POSITIVE 1 0.0017
86 MORBID THOUGHTS 2 0.0017
87 TERMINAL INSOMNIA 3 0.0017
88 ADENOMYOSIS 1 0.0017
89 UTERINE PERFORATION 14 0.0017
90 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 9 0.0017
91 TOOTH EROSION 2 0.0016
92 INFUSION SITE WARMTH 2 0.0016
93 MENSTRUATION IRREGULAR 43 0.0016
94 CORTISOL INCREASED 1 0.0016
95 BLOOD CORTISOL DECREASED 1 0.0016
96 ENDOCRINE DISORDER 2 0.0016
97 ABDOMINAL OPERATION 2 0.0015
98 GALLBLADDER INJURY 3 0.0015
99 HIRSUTISM 2 0.0015
100 BONE DEFORMITY 1 0.0015
101 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 2 0.0015
102 MENSTRUATION DELAYED 16 0.0015
103 HYPOMENORRHOEA 4 0.0015
104 PREMENSTRUAL SYNDROME 2 0.0015
105 INCISIONAL HERNIA 2 0.0014
106 MAST CELL ACTIVATION SYNDROME 2 0.0014
107 ATTENTION DEFICIT HYPERACTIVITY DISORDER 6 0.0014
108 H1N1 INFLUENZA 2 0.0014
109 BLOOD ELECTROLYTES DECREASED 2 0.0014
110 BILIARY COLIC 4 0.0014
111 PREGNANCY ON CONTRACEPTIVE 2 0.0014
112 GENERALISED ANXIETY DISORDER 2 0.0014
113 AMINO ACID LEVEL INCREASED 1 0.0013
114 SKIN STRIAE 2 0.0013
115 INFECTIOUS MONONUCLEOSIS 3 0.0013
116 EPICONDYLITIS 2 0.0013
117 COMPLICATION OF PREGNANCY 1 0.0013
118 INJECTION SITE PARAESTHESIA 2 0.0013
119 POLYCYSTIC OVARIES 2 0.0013
120 MENOPAUSAL SYMPTOMS 3 0.0013
121 INFERTILITY FEMALE 2 0.0013
122 MENORRHAGIA 25 0.0013
123 AMENORRHOEA 22 0.0013
124 CYSTITIS INTERSTITIAL 2 0.0012
125 DISINHIBITION 2 0.0012
126 CHOLECYSTITIS ACUTE 7 0.0012
127 COSTOCHONDRITIS 2 0.0012
128 HEAVY MENSTRUAL BLEEDING 11 0.0012
129 FEELING DRUNK 9 0.0012
130 INTERCEPTED PRODUCT DISPENSING ERROR 2 0.0012
131 VENA CAVA THROMBOSIS 2 0.0012
132 EDUCATIONAL PROBLEM 2 0.0012
133 LACTOSE INTOLERANCE 3 0.0012
134 ATONIC SEIZURES 1 0.0012
135 ABSCESS DRAINAGE 1 0.0012
136 ARTERIAL STENOSIS 1 0.0011
137 CHOLECYSTECTOMY 13 0.0011
138 ILEAL STENOSIS 2 0.0011
139 CATHETER MANAGEMENT 1 0.0011
140 SKIN DISCOMFORT 3 0.0011
141 VAGINAL HAEMORRHAGE 48 0.0011
142 CEREBRAL VENOUS THROMBOSIS 2 0.0011
143 DERMATITIS ATOPIC 58 0.0011
144 BODY TEMPERATURE ABNORMAL 2 0.0011
145 CYSTIC FIBROSIS 6 0.0011
146 ADVERSE FOOD REACTION 1 0.0011
147 FEELING OF DESPAIR 5 0.0011
148 TUNNEL VISION 2 0.0011
149 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 18 0.0011
150 AUTOIMMUNE THYROIDITIS 4 0.0011
151 CEREBRAL PALSY 1 0.0011
152 ARNOLD-CHIARI MALFORMATION 1 0.0010
153 ENDOMETRIOSIS 5 0.0010
154 IMPAIRED QUALITY OF LIFE 15 0.0010
155 EARLY SATIETY 2 0.0010
156 RHINOVIRUS INFECTION 4 0.0010
157 HORMONE LEVEL ABNORMAL 5 0.0010
158 NEGATIVE THOUGHTS 3 0.0010
159 INFUSION SITE REACTION 3 0.0010
160 ACNE CYSTIC 3 0.0010
161 CHANGE OF BOWEL HABIT 2 0.0010
162 VENOUS THROMBOSIS LIMB 2 0.0010
163 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 2 0.0010
164 INSULIN RESISTANCE 2 0.0010
165 SELF-INJURIOUS IDEATION 4 0.0010
166 INFUSION SITE PRURITUS 3 0.0009
167 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 1 0.0009
168 BLOOD SODIUM ABNORMAL 1 0.0009
169 CUSHINGOID 3 0.0009
170 GASTRIC CANCER STAGE IV 2 0.0009
171 BLOOD TESTOSTERONE INCREASED 2 0.0009
172 BREAST TENDERNESS 7 0.0009
173 BINGE EATING 1 0.0009
174 CLAUSTROPHOBIA 1 0.0009
175 OLIGOMENORRHOEA 2 0.0009
176 CERVICAL DYSPLASIA 2 0.0009
177 BIPOLAR I DISORDER 2 0.0009
178 MIDDLE EAR EFFUSION 2 0.0009
179 COMPLEX PARTIAL SEIZURES 1 0.0009
180 CATHETER SITE DISCHARGE 1 0.0009
181 PERIORBITAL SWELLING 5 0.0009
182 INITIAL INSOMNIA 9 0.0009
183 INJECTION SITE PAPULE 4 0.0009
184 ADMINISTRATION SITE PAIN 1 0.0009
185 FLAT AFFECT 2 0.0009
186 UTERINE DISORDER 2 0.0009
187 ORAL SURGERY 2 0.0009
188 PRURITUS GENITAL 2 0.0008
189 SINUS OPERATION 2 0.0008
190 PAINFUL RESPIRATION 2 0.0008
191 SKIN FRAGILITY 2 0.0008
192 SKIN FISSURES 16 0.0008
193 INFLAMMATORY BOWEL DISEASE 8 0.0008
194 INFUSION SITE SWELLING 5 0.0008
195 SNORING 3 0.0008
196 DERMATITIS CONTACT 9 0.0008
197 BAND SENSATION 1 0.0008
198 ENDODONTIC PROCEDURE 2 0.0008
199 ADNEXA UTERI PAIN 1 0.0008
200 BILIARY OBSTRUCTION 1 0.0008
201 APPLICATION SITE PARAESTHESIA 1 0.0008
202 TEMPOROMANDIBULAR JOINT SYNDROME 2 0.0007
203 ANAL ABSCESS 4 0.0007
204 GALLBLADDER OPERATION 3 0.0007
205 WRONG PRODUCT ADMINISTERED 5 0.0007
206 MIGRAINE WITH AURA 2 0.0007
207 IMPAIRED GASTRIC EMPTYING 10 0.0007
208 AGORAPHOBIA 1 0.0007
209 GALLBLADDER DISORDER 13 0.0007
210 SOCIAL PROBLEM 3 0.0007
211 DRUG SCREEN FALSE POSITIVE 2 0.0007
212 HAIR GROWTH ABNORMAL 5 0.0007
213 EOSINOPHILIC OESOPHAGITIS 2 0.0007
214 CHRONIC FATIGUE SYNDROME 1 0.0007
215 TRICHORRHEXIS 2 0.0007
216 PELVIC PAIN 13 0.0007
217 INFUSION SITE ERYTHEMA 6 0.0007
218 APPENDIX DISORDER 1 0.0007
219 CONNECTIVE TISSUE DISORDER 1 0.0007
220 UTERINE HAEMORRHAGE 3 0.0007
221 INJECTION SITE SCAR 2 0.0007
222 HEPATIC LESION 3 0.0007
223 AUTONOMIC NERVOUS SYSTEM IMBALANCE 2 0.0007
224 COCCYDYNIA 1 0.0007
225 PRODUCT SUBSTITUTION ISSUE 39 0.0007
226 COMPLEX REGIONAL PAIN SYNDROME 1 0.0007
227 ANKLE OPERATION 1 0.0007
228 SINUS HEADACHE 4 0.0007
229 AXILLARY PAIN 1 0.0007
230 CHOLECYSTITIS 8 0.0007
231 ATYPICAL PNEUMONIA 2 0.0007
232 INJECTION SITE URTICARIA 16 0.0007
233 POOR QUALITY SLEEP 14 0.0006
234 AFFECTIVE DISORDER 5 0.0006
235 ANTIPHOSPHOLIPID SYNDROME 1 0.0006
236 VULVOVAGINAL DRYNESS 2 0.0006
237 ANTINUCLEAR ANTIBODY POSITIVE 2 0.0006
238 HEPATIC NEOPLASM 2 0.0006
239 EXPOSURE DURING BREAST FEEDING 2 0.0006
240 APPETITE DISORDER 4 0.0006
241 NUCLEAR MAGNETIC RESONANCE IMAGING ABNORMAL 2 0.0006
242 BLOOD CALCIUM ABNORMAL 1 0.0006
243 LYME DISEASE 2 0.0006
244 MIGRAINE 57 0.0006
245 POST-TRAUMATIC STRESS DISORDER 4 0.0006
246 MOOD SWINGS 19 0.0006
247 BLOOD IRON DECREASED 7 0.0006
248 VENTRICULAR EXTRASYSTOLES 6 0.0006
249 SLEEP APNOEA SYNDROME 11 0.0006
250 SKIN SWELLING 5 0.0006
251 BREAST DISCHARGE 1 0.0006
252 EAR PRURITUS 2 0.0006
253 ALOPECIA AREATA 1 0.0006
254 BURNS SECOND DEGREE 1 0.0006
255 MUSCLE CONTRACTIONS INVOLUNTARY 2 0.0006
256 HANGOVER 2 0.0006
257 BREAST CYST 1 0.0006
258 EAR INFECTION 15 0.0006
259 IMPAIRED WORK ABILITY 12 0.0006
260 HEREDITARY ANGIOEDEMA 6 0.0006
261 FOREIGN BODY IN REPRODUCTIVE TRACT 5 0.0006
262 PHARYNGITIS STREPTOCOCCAL 6 0.0006
263 MOOD ALTERED 15 0.0005
264 MAJOR DEPRESSION 4 0.0005
265 SEBORRHOEA 2 0.0005
266 BLOOD THYROID STIMULATING HORMONE ABNORMAL 1 0.0005
267 INJURY 38 0.0005
268 ARTHROPOD BITE 4 0.0005
269 HYPERACUSIS 2 0.0005
270 NEURODERMATITIS 2 0.0005
271 AURA 1 0.0005
272 ECZEMA 28 0.0005
273 BLADDER SPASM 1 0.0005
274 BLOOD IRON INCREASED 1 0.0005
275 BLOOD BICARBONATE DECREASED 1 0.0005
276 PRODUCT STORAGE ISSUE 2 0.0005
277 BONE MARROW TRANSPLANT 1 0.0005
278 INTENTIONAL DOSE OMISSION 15 0.0005
279 PANIC ATTACK 19 0.0005
280 THYROID MASS 2 0.0005
281 ADRENAL DISORDER 1 0.0005
282 FOOD ALLERGY 4 0.0005
283 ARTERIAL THROMBOSIS 1 0.0005
284 PRODUCT TASTE ABNORMAL 7 0.0005
285 CONVERSION DISORDER 1 0.0005
286 ADRENOCORTICAL INSUFFICIENCY ACUTE 1 0.0005
287 EMBEDDED DEVICE 5 0.0005
288 SYMPTOM RECURRENCE 3 0.0005
289 OVARIAN CYST 5 0.0005
290 GASTROENTERITIS VIRAL 9 0.0005
291 TRIGEMINAL NEURALGIA 2 0.0005
292 FUNGAL SKIN INFECTION 2 0.0005
293 ENURESIS 2 0.0005
294 SEASONAL ALLERGY 7 0.0005
295 VAGINAL DISCHARGE 5 0.0005
296 MENISCUS INJURY 3 0.0005
297 HYPERAESTHESIA 4 0.0005
298 CHEST INJURY 1 0.0005
299 UPPER RESPIRATORY TRACT INFECTION 22 0.0005
300 PHOTOPSIA 3 0.0005
301 BREAST PAIN 5 0.0005
302 CD4 LYMPHOCYTES DECREASED 1 0.0005
303 GALACTORRHOEA 3 0.0005
304 TEARFULNESS 2 0.0005
305 ABSCESS INTESTINAL 1 0.0005
306 AMYOTROPHIC LATERAL SCLEROSIS 1 0.0005
307 PRODUCT DOSE OMISSION IN ERROR 13 0.0005
308 PULMONARY FUNCTION TEST DECREASED 2 0.0005
309 PRODUCT FORMULATION ISSUE 3 0.0005
310 COLONOSCOPY 1 0.0005
311 IMPLANT SITE PAIN 2 0.0004
312 QUALITY OF LIFE DECREASED 6 0.0004
313 BREAST MASS 3 0.0004
314 SURGERY 26 0.0004
315 CHRONIC GASTRITIS 1 0.0004
316 COMPLICATION OF DEVICE REMOVAL 8 0.0004
317 MATERNAL EXPOSURE BEFORE PREGNANCY 3 0.0004
318 DYSPAREUNIA 2 0.0004
319 APHTHOUS STOMATITIS 1 0.0004
320 LOCALISED OEDEMA 2 0.0004
321 PERFORMANCE STATUS DECREASED 2 0.0004
322 UMBILICAL HERNIA 2 0.0004
323 PAPULE 3 0.0004
324 ABORTION INDUCED 4 0.0004
325 SARCOIDOSIS 2 0.0004
326 PULMONARY EMBOLISM 40 0.0004
327 PANIC REACTION 3 0.0004
328 PRODUCT DISPENSING ERROR 9 0.0004
329 EAR PAIN 8 0.0004
330 AUTOIMMUNE DISORDER 4 0.0004
331 VITREOUS FLOATERS 4 0.0004
332 PSYCHIATRIC SYMPTOM 3 0.0004
333 PARANOIA 7 0.0004
334 CARTILAGE INJURY 1 0.0004
335 DRUG EFFECT LESS THAN EXPECTED 6 0.0004
336 SKIN HAEMORRHAGE 6 0.0004
337 BLOOD PRESSURE SYSTOLIC ABNORMAL 1 0.0004
338 LIGAMENT SPRAIN 4 0.0004
339 FOOT OPERATION 2 0.0004
340 MUCOUS STOOLS 2 0.0004
341 INFLAMMATORY MARKER INCREASED 2 0.0004
342 ABDOMINAL TENDERNESS 2 0.0004
343 PROTEIN URINE PRESENT 2 0.0004
344 DEEP VEIN THROMBOSIS 26 0.0004
345 COLD SWEAT 7 0.0004
346 PROCEDURAL PAIN 11 0.0004
347 LYMPHADENOPATHY 14 0.0004
348 DISCOMFORT 24 0.0004
349 INSURANCE ISSUE 6 0.0004
350 THERAPEUTIC RESPONSE SHORTENED 13 0.0004
351 ABDOMINAL INFECTION 1 0.0004
352 VIRAL INFECTION 13 0.0004
353 ABNORMAL UTERINE BLEEDING 1 0.0004
354 DISTURBANCE IN ATTENTION 21 0.0004
355 INFUSION SITE PAIN 5 0.0004
356 TEMPERATURE INTOLERANCE 4 0.0004
357 TENDONITIS 6 0.0004
358 TRISMUS 2 0.0004
359 APHTHOUS ULCER 3 0.0004
360 TOOTHACHE 7 0.0004
361 CATHETER SITE PAIN 1 0.0004
362 PRODUCT DOSE OMISSION 25 0.0004
363 BRAIN FOG 6 0.0004
364 WEIGHT FLUCTUATION 4 0.0004
365 INCORRECT PRODUCT STORAGE 5 0.0004
366 INJECTION SITE DISCOMFORT 4 0.0004
367 THERAPEUTIC RESPONSE UNEXPECTED 17 0.0004
368 ANGIONEUROTIC OEDEMA 1 0.0004
369 MIDDLE INSOMNIA 7 0.0004
370 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 18 0.0004
371 INJECTION SITE PRURITUS 25 0.0004
372 ANAL FISSURE 2 0.0004
373 ANXIETY 106 0.0004
374 OVERWEIGHT 2 0.0004
375 BREAST SWELLING 1 0.0004
376 BRUXISM 2 0.0004
377 SINUSITIS 38 0.0004
378 SINUS CONGESTION 5 0.0004
379 HIP SURGERY 2 0.0004
380 CHONDROPATHY 1 0.0004
381 FEELING JITTERY 7 0.0004
382 PRODUCT PRESCRIBING ISSUE 8 0.0004
383 PULMONARY THROMBOSIS 4 0.0004
384 CHOLELITHIASIS 12 0.0004
385 CLONUS 1 0.0004
386 INJECTION SITE SWELLING 28 0.0004
387 INJECTION SITE REACTION 25 0.0004
388 HUNGER 5 0.0004
389 HEART RATE ABNORMAL 2 0.0004
390 INJECTION SITE RASH 11 0.0004
391 CRYING 13 0.0004
392 KIDNEY INFECTION 7 0.0004
393 COLECTOMY 2 0.0004
394 CEREBRAL THROMBOSIS 1 0.0004
395 INADEQUATE ANALGESIA 3 0.0004
396 PERONEAL NERVE PALSY 2 0.0004
397 MICTURITION URGENCY 4 0.0003
398 SUICIDAL IDEATION 32 0.0003
399 THROMBOSIS 28 0.0003
400 SOCIAL AVOIDANT BEHAVIOUR 2 0.0003
401 ABDOMINAL DISTENSION 36 0.0003
402 ADENOVIRUS INFECTION 1 0.0003
403 LOCAL SWELLING 6 0.0003
404 DEPRESSION 78 0.0003
405 ANHEDONIA 9 0.0003
406 HYPOVOLAEMIA 2 0.0003
407 FEELING OF BODY TEMPERATURE CHANGE 2 0.0003
408 CREPITATIONS 1 0.0003
409 LOSS OF LIBIDO 3 0.0003
410 DIABETIC KETOACIDOSIS 8 0.0003
411 INJECTION SITE VESICLES 2 0.0003
412 ACNE 25 0.0003
413 ADRENAL INSUFFICIENCY 4 0.0003
414 NOCTURIA 4 0.0003
415 DRUG DISPENSING ERROR 5 0.0003
416 IRRITABLE BOWEL SYNDROME 7 0.0003
417 LIVER FUNCTION TEST INCREASED 7 0.0003
418 INJECTION SITE BRUISING 26 0.0003
419 PHARYNGEAL OEDEMA 5 0.0003
420 EMOTIONAL DISORDER 10 0.0003
421 MUSCULOSKELETAL CHEST PAIN 5 0.0003
422 URTICARIA 54 0.0003
423 INFUSION SITE EXTRAVASATION 2 0.0003
424 APPENDICITIS 3 0.0003
425 BLEPHAROSPASM 2 0.0003
426 THERAPEUTIC RESPONSE CHANGED 2 0.0003
427 DISEASE RECURRENCE 15 0.0003
428 BLADDER PAIN 1 0.0003
429 BILE DUCT STONE 1 0.0003
430 SUPRAVENTRICULAR TACHYCARDIA 3 0.0003
431 NIGHT SWEATS 10 0.0003
432 CARDIAC FLUTTER 2 0.0003
433 COVID-19 54 0.0003
434 PHARYNGEAL SWELLING 3 0.0003
435 INJECTION SITE ERYTHEMA 38 0.0003
436 BREAST ENLARGEMENT 1 0.0003
437 KNEE OPERATION 3 0.0003
438 PRODUCT PREPARATION ISSUE 2 0.0003
439 SOMNAMBULISM 2 0.0003
440 WALKING AID USER 2 0.0003
441 GENERALISED TONIC-CLONIC SEIZURE 5 0.0003
442 BLADDER DISORDER 3 0.0003
443 ADVERSE REACTION 4 0.0003
444 FUNGAL INFECTION 10 0.0003
445 SKIN MASS 2 0.0003
446 ANXIETY DISORDER 1 0.0003
447 EYE PRURITUS 10 0.0003
448 BRONCHITIS 22 0.0003
449 TOOTH ABSCESS 3 0.0003
450 SLUGGISHNESS 3 0.0003
451 DRY SKIN 39 0.0003
452 SCAR 5 0.0003
453 ASTHMA 33 0.0003
454 INJECTION SITE WARMTH 6 0.0003
455 ONYCHOCLASIS 2 0.0003
456 RESPIRATION ABNORMAL 2 0.0003
457 EXPOSURE DURING PREGNANCY 18 0.0003
458 DROOLING 2 0.0003
459 EYE DISCHARGE 3 0.0003
460 ABDOMINAL PAIN 67 0.0003
461 TENDERNESS 3 0.0003
462 FORMICATION 2 0.0003
463 DERMATITIS 6 0.0003
464 MOUTH ULCERATION 6 0.0003
465 HEADACHE 178 0.0003
466 PRODUCT DOSE OMISSION ISSUE 83 0.0003
467 THERMAL BURN 2 0.0003
468 CONJUNCTIVAL HYPERAEMIA 1 0.0003
469 FEAR OF INJECTION 2 0.0003
470 APPENDICECTOMY 1 0.0003
471 BREAST CANCER METASTATIC 3 0.0003
472 APPARENT DEATH 1 0.0003
473 ABDOMINAL PAIN LOWER 7 0.0003
474 SKIN LACERATION 3 0.0003
475 COMPLICATION ASSOCIATED WITH DEVICE 4 0.0003
476 OESOPHAGITIS 3 0.0003
477 DYSSTASIA 8 0.0003
478 INTENTIONAL UNDERDOSE 2 0.0003
479 BLOOD PHOSPHORUS DECREASED 1 0.0003
480 SKIN EXFOLIATION 23 0.0003
481 BLINDNESS TRANSIENT 2 0.0003
482 DENTAL CARIES 3 0.0003
483 HYPOPHOSPHATAEMIA 2 0.0003
484 NERVE INJURY 3 0.0003
485 CONJUNCTIVITIS 5 0.0003
486 SLEEP DISORDER 19 0.0003
487 EYE SWELLING 10 0.0003
488 RESPIRATORY TRACT INFECTION 7 0.0003
489 COLITIS ULCERATIVE 12 0.0003
490 RASH PAPULAR 6 0.0003
491 MUSCLE SPASMS 49 0.0003
492 TUBULOINTERSTITIAL NEPHRITIS 5 0.0003
493 NAUSEA 211 0.0003
494 CHRONIC SINUSITIS 1 0.0003
495 ANGER 9 0.0003
496 PHOTOPHOBIA 5 0.0003
497 HYPERHIDROSIS 34 0.0003
498 FOOT FRACTURE 5 0.0003
499 ABDOMINAL PAIN UPPER 54 0.0003
500 DEVICE PHYSICAL PROPERTY ISSUE 2 0.0003
501 DRY EYE 13 0.0003
502 FEAR 7 0.0003
503 EYELID OEDEMA 3 0.0003
504 FLUSHING 26 0.0003
505 NASAL CONGESTION 15 0.0003
506 DEVICE DISLOCATION 11 0.0003
507 SINUS DISORDER 5 0.0003
508 GINGIVAL PAIN 2 0.0003
509 OBESITY 4 0.0003
510 INJECTION SITE PAIN 77 0.0003
511 FEELING ABNORMAL 60 0.0003
512 PRODUCT QUALITY ISSUE 34 0.0003
513 PREGNANCY 5 0.0002
514 BLEPHARITIS 1 0.0002
515 OBSESSIVE-COMPULSIVE DISORDER 2 0.0002
516 NERVOUSNESS 13 0.0002
517 SENSORY LOSS 2 0.0002
518 LOCALISED INFECTION 6 0.0002
519 RHINITIS 2 0.0002
520 PARAESTHESIA 39 0.0002
521 MYASTHENIA GRAVIS 2 0.0002
522 RHINORRHOEA 16 0.0002
523 FRUSTRATION TOLERANCE DECREASED 2 0.0002
524 APPLICATION SITE DISCOLOURATION 1 0.0002
525 POST PROCEDURAL INFECTION 2 0.0002
526 SUBSTANCE ABUSE 2 0.0002
527 PRODUCT PREPARATION ERROR 5 0.0002
528 EYE IRRITATION 14 0.0002
529 MANIA 4 0.0002
530 ANAPHYLACTOID REACTION 1 0.0002
531 ILLNESS 25 0.0002
532 CYST 3 0.0002
533 INJECTION SITE DISCOLOURATION 3 0.0002
534 NEPHROLITHIASIS 11 0.0002
535 LIVE BIRTH 2 0.0002
536 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 17 0.0002
537 DERMATITIS ALLERGIC 3 0.0002
538 PSYCHOTIC DISORDER 7 0.0002
539 PRURITUS 91 0.0002
540 VITAMIN D DECREASED 2 0.0002
541 DYSPEPSIA 23 0.0002
542 ALCOHOLISM 1 0.0002
543 GENITAL HAEMORRHAGE 3 0.0002
544 EXPOSURE VIA SKIN CONTACT 6 0.0002
545 PYELONEPHRITIS 2 0.0002
546 VOMITING 108 0.0002
547 JOINT STIFFNESS 6 0.0002
548 SYRINGE ISSUE 4 0.0002
549 NASOPHARYNGITIS 42 0.0002
550 DEPRESSED MOOD 12 0.0002
551 CATHETERISATION CARDIAC 1 0.0002
552 UNEVALUABLE EVENT 17 0.0002
553 PREGNANCY WITH CONTRACEPTIVE DEVICE 2 0.0002
554 HEART RATE INCREASED 22 0.0002
555 PSORIASIS 29 0.0002
556 PRODUCT USE IN UNAPPROVED INDICATION 55 0.0002
557 DEVICE BREAKAGE 9 0.0002
558 HYPOAESTHESIA 33 0.0002
559 CONDITION AGGRAVATED 67 0.0002
560 LIP DRY 2 0.0002
561 BLOOD THYROID STIMULATING HORMONE DECREASED 1 0.0002
562 RESTLESS LEGS SYNDROME 4 0.0002
563 HIDRADENITIS 2 0.0002
564 ABDOMINAL HERNIA 1 0.0002
565 CENTRAL NERVOUS SYSTEM LESION 3 0.0002
566 NERVE COMPRESSION 2 0.0002
567 SEIZURE 25 0.0002
568 RASH 94 0.0002
569 PRODUCT DISTRIBUTION ISSUE 2 0.0002
570 ARTHRITIS INFECTIVE 1 0.0002
571 HYPOMAGNESAEMIA 3 0.0002
572 APHONIA 3 0.0002
573 ERYTHEMA MULTIFORME 2 0.0002
574 THERAPEUTIC RESPONSE DECREASED 13 0.0002
575 CARPAL TUNNEL SYNDROME 3 0.0002
576 COGNITIVE DISORDER 10 0.0002
577 INSOMNIA 57 0.0002
578 SOMNOLENCE 43 0.0002
579 MATERNAL EXPOSURE DURING PREGNANCY 19 0.0002
580 BLOOD PROLACTIN INCREASED 1 0.0002
581 SINUS TACHYCARDIA 3 0.0002
582 ABDOMINAL DISCOMFORT 35 0.0002
583 AFFECT LABILITY 2 0.0002
584 APHAGIA 1 0.0002
585 INFECTION 30 0.0002
586 EMOTIONAL DISTRESS 25 0.0002
587 APATHY 3 0.0002
588 PRESYNCOPE 5 0.0002
589 NEURALGIA 5 0.0002
590 HEPATIC ENZYME INCREASED 14 0.0002
591 GASTRIC DISORDER 7 0.0002
592 THERAPY CHANGE 2 0.0002
593 BREATH SOUNDS ABNORMAL 1 0.0002
594 COMPLICATION OF DEVICE INSERTION 4 0.0002
595 IRRITABILITY 12 0.0002
596 SYSTEMIC LUPUS ERYTHEMATOSUS 7 0.0002
597 PSORIATIC ARTHROPATHY 8 0.0002
598 VERTIGO 12 0.0002
599 MOTOR DYSFUNCTION 2 0.0002
600 BODY TEMPERATURE INCREASED 4 0.0002
601 AMMONIA INCREASED 1 0.0002
602 FEELING HOT 12 0.0002
603 NEUTROPHIL COUNT INCREASED 2 0.0002
604 MYALGIA 33 0.0002
605 INTENTIONAL PRODUCT USE ISSUE 17 0.0002
606 POOR VENOUS ACCESS 2 0.0002
607 PAIN 118 0.0002
608 POLLAKIURIA 8 0.0002
609 HERPES ZOSTER 11 0.0002
610 DIZZINESS 95 0.0002
611 GASTRITIS 5 0.0002
612 GASTROINTESTINAL DISORDER 17 0.0002
613 POOR QUALITY PRODUCT ADMINISTERED 2 0.0002
614 RENAL PAIN 2 0.0002
615 ULCER 3 0.0002
616 ALOPECIA 37 0.0002
617 SENSORY DISTURBANCE 3 0.0002
618 GASTROOESOPHAGEAL REFLUX DISEASE 15 0.0002
619 DECREASED ACTIVITY 2 0.0002
620 MUSCLE TIGHTNESS 3 0.0002
621 BEHAVIOUR DISORDER 1 0.0002
622 BIPOLAR DISORDER 2 0.0002
623 MENTAL DISORDER 8 0.0002
624 INTERVERTEBRAL DISC PROTRUSION 4 0.0002
625 ASPIRATION 2 0.0002
626 EYE DISORDER 6 0.0002
627 WHITE BLOOD CELL COUNT INCREASED 7 0.0002
628 FATIGUE 142 0.0002
629 STAPHYLOCOCCAL INFECTION 6 0.0002
630 URINARY TRACT INFECTION 31 0.0002
631 AUTISM SPECTRUM DISORDER 1 0.0002
632 DEAFNESS UNILATERAL 1 0.0002
633 TOOTH FRACTURE 2 0.0002
634 ABNORMAL DREAMS 5 0.0002
635 ANAPHYLACTIC REACTION 10 0.0002
636 TOOTH DISORDER 4 0.0002
637 HYPERTENSIVE CRISIS 2 0.0002
638 WEIGHT INCREASED 40 0.0002
639 DEVICE ISSUE 16 0.0002
640 THROAT IRRITATION 8 0.0002
641 SKIN INFECTION 2 0.0002
642 CHEST PAIN 33 0.0002
643 OCULAR DISCOMFORT 2 0.0002
644 HYPERSENSITIVITY 33 0.0002
645 CANDIDA INFECTION 3 0.0002
646 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 32 0.0002
647 PAIN IN JAW 5 0.0002
648 PRODUCT AVAILABILITY ISSUE 4 0.0002
649 SCAB 2 0.0002
650 THERAPY CESSATION 9 0.0002
651 ABORTION SPONTANEOUS 7 0.0002
652 SKIN DISCOLOURATION 8 0.0002
653 MUSCLE TWITCHING 4 0.0002
654 HOT FLUSH 13 0.0002
655 DEHYDRATION 23 0.0002
656 POST PROCEDURAL HAEMORRHAGE 2 0.0002
657 RASH MACULAR 6 0.0002
658 BURNING SENSATION 12 0.0002
659 CHILLS 20 0.0002
660 LYMPHOCYTE COUNT DECREASED 3 0.0002
661 DRUG ERUPTION 3 0.0002
662 TREMOR 28 0.0002
663 THIRST 3 0.0002
664 DRUG EFFECT DECREASED 9 0.0002
665 BLOOD POTASSIUM DECREASED 5 0.0002
666 MENTAL IMPAIRMENT 4 0.0002
667 FIBROMYALGIA 4 0.0002
668 END STAGE RENAL DISEASE 3 0.0002
669 RESTLESSNESS 6 0.0002
670 MUSCLE SPASTICITY 2 0.0002
671 HAEMORRHAGE 17 0.0002
672 CARDIOMEGALY 2 0.0002
673 LIMB DISCOMFORT 5 0.0002
674 INFLUENZA 18 0.0002
675 ARTHRALGIA 67 0.0002
676 THINKING ABNORMAL 3 0.0002
677 HAIR COLOUR CHANGES 2 0.0002
678 MULTIPLE SCLEROSIS RELAPSE 11 0.0002
679 CONSTIPATION 35 0.0002
680 MEMORY IMPAIRMENT 22 0.0002
681 SWOLLEN TONGUE 5 0.0002
682 PRODUCT STORAGE ERROR 14 0.0002
683 INFLUENZA LIKE ILLNESS 13 0.0002
684 WEIGHT DECREASED 44 0.0002
685 MUSCULOSKELETAL DISORDER 3 0.0002
686 INJECTION SITE IRRITATION 2 0.0002
687 DEVICE DEPLOYMENT ISSUE 2 0.0002
688 DEVICE MALFUNCTION 11 0.0002
689 HYPOPHAGIA 4 0.0002
690 LETHARGY 9 0.0002
691 SEROTONIN SYNDROME 3 0.0002
692 ANOREXIA 2 0.0002
693 ERUCTATION 3 0.0002
694 HIATUS HERNIA 2 0.0002
695 INJECTION SITE INDURATION 2 0.0002
696 THERAPY INTERRUPTED 11 0.0002
697 DIARRHOEA 99 0.0002
698 BRADYPHRENIA 1 0.0002
699 SKIN IRRITATION 7 0.0002
700 TINNITUS 7 0.0002
701 IMPAIRED HEALING 5 0.0002
702 SARS-COV-2 TEST POSITIVE 2 0.0002
703 DISORIENTATION 6 0.0002
704 OROPHARYNGEAL PAIN 14 0.0002
705 CORONAVIRUS INFECTION 1 0.0002
706 INFUSION RELATED REACTION 10 0.0002
707 PRESCRIBED UNDERDOSE 3 0.0002
708 LIP SWELLING 5 0.0001
709 SWELLING 14 0.0001
710 HAIR TEXTURE ABNORMAL 2 0.0001
711 PAIN OF SKIN 4 0.0001
712 INTENTIONAL SELF-INJURY 3 0.0001
713 PRODUCT ADMINISTRATION ERROR 3 0.0001
714 BRONCHIECTASIS 1 0.0001
715 MALAISE 65 0.0001
716 FEEDING DISORDER 3 0.0001
717 RASH PRURITIC 8 0.0001
718 OCULAR HYPERAEMIA 7 0.0001
719 INJURY ASSOCIATED WITH DEVICE 3 0.0001
720 PNEUMONITIS 4 0.0001
721 AKATHISIA 2 0.0001
722 RASH ERYTHEMATOUS 7 0.0001
723 BACK PAIN 34 0.0001
724 TOOTH LOSS 3 0.0001
725 MENTAL STATUS CHANGES 4 0.0001
726 BLOOD PRESSURE INCREASED 22 0.0001
727 DEFAECATION URGENCY 1 0.0001
728 KNEE ARTHROPLASTY 3 0.0001
729 HALLUCINATION, VISUAL 3 0.0001
730 FLATULENCE 8 0.0001
731 ADVERSE EVENT 13 0.0001
732 RETCHING 3 0.0001
733 PARALYSIS 2 0.0001
734 DRUG DOSE OMISSION 23 0.0001
735 PARAESTHESIA ORAL 2 0.0001
736 ALTERED STATE OF CONSCIOUSNESS 3 0.0001
737 SWELLING FACE 9 0.0001
738 ANOSMIA 2 0.0001
739 WRONG TECHNIQUE IN DRUG USAGE PROCESS 5 0.0001
740 FLUID RETENTION 7 0.0001
741 CLOSTRIDIUM DIFFICILE INFECTION 3 0.0001
742 NEEDLE ISSUE 4 0.0001
743 GASTROENTERITIS 2 0.0001
744 MUSCULOSKELETAL STIFFNESS 12 0.0001
745 PALPITATIONS 16 0.0001
746 DEVICE DIFFICULT TO USE 9 0.0001
747 PYREXIA 47 0.0001
748 COUGH 38 0.0001
749 INJECTION SITE MASS 5 0.0001
750 STEVENS-JOHNSON SYNDROME 3 0.0001
751 HEPATOTOXICITY 3 0.0001
752 DYSGEUSIA 10 0.0001
753 SNEEZING 3 0.0001
754 RESPIRATORY DISORDER 4 0.0001
755 THERAPY NON-RESPONDER 6 0.0001
756 DYSARTHRIA 5 0.0001
757 HYPOAESTHESIA ORAL 2 0.0001
758 RHEUMATOID ARTHRITIS 15 0.0001
759 OSTEOPENIA 2 0.0001
760 DEVICE FAILURE 2 0.0001
761 ACIDOSIS 1 0.0001
762 BOWEL MOVEMENT IRREGULARITY 1 0.0001
763 DEVICE RELATED INFECTION 2 0.0001
764 THYROID DISORDER 2 0.0001
765 ANKLE FRACTURE 2 0.0001
766 CONCUSSION 1 0.0001
767 PAIN IN EXTREMITY 38 0.0001
768 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 7 0.0001
769 PRODUCT USE COMPLAINT 2 0.0001
770 ABNORMAL BEHAVIOUR 5 0.0001
771 SKIN BURNING SENSATION 9 0.0001
772 CYSTITIS 4 0.0001
773 SCIATICA 2 0.0001
774 ABSCESS 2 0.0001
775 INJECTION SITE HAEMORRHAGE 10 0.0001
776 DRUG INEFFECTIVE 164 0.0001
777 EYE PAIN 7 0.0001
778 VISION BLURRED 17 0.0001
779 DEVICE EXPULSION 8 0.0001
780 OEDEMA PERIPHERAL 15 0.0001
781 AMNESIA 8 0.0001
782 LIVER INJURY 3 0.0001
783 ABNORMAL FAECES 1 0.0001
784 DYSPNOEA 69 0.0001
785 PHOTOSENSITIVITY REACTION 2 0.0001
786 PSYCHOMOTOR HYPERACTIVITY 2 0.0001
787 SKIN DISORDER 4 0.0001
788 URINARY RETENTION 4 0.0001
789 GAIT INABILITY 4 0.0001
790 ROAD TRAFFIC ACCIDENT 5 0.0001
791 WITHDRAWAL SYNDROME 5 0.0001
792 CELLULITIS 6 0.0001
793 GLYCOSYLATED HAEMOGLOBIN INCREASED 3 0.0001
794 HYPERTENSION 25 0.0001
795 CHEST DISCOMFORT 12 0.0001
796 PRODUCT USE ISSUE 22 0.0001
797 PERIPHERAL SWELLING 18 0.0001
798 DYSPHAGIA 11 0.0001
799 BLOOD MAGNESIUM DECREASED 1 0.0001
800 NIGHTMARE 4 0.0001
801 DEVICE DEFECTIVE 2 0.0001
802 ORTHOSTATIC HYPOTENSION 2 0.0001
803 SEDATION 3 0.0001
804 APPLICATION SITE ERYTHEMA 3 0.0001
805 MUSCULAR WEAKNESS 13 0.0001
806 BLOOD CALCIUM INCREASED 1 0.0001
807 DRUG INTERACTION 18 0.0001
808 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 8 0.0001
809 DECREASED APPETITE 26 0.0001
810 ERYTHEMA 23 0.0001
811 THERAPEUTIC PRODUCT EFFECT DECREASED 5 0.0001
812 ADVERSE DRUG REACTION 10 0.0001
813 ANAL INCONTINENCE 1 0.0001
814 FREQUENT BOWEL MOVEMENTS 3 0.0001
815 LIMB INJURY 3 0.0001
816 BLOOD THYROID STIMULATING HORMONE INCREASED 1 0.0001
817 DIVERTICULITIS 3 0.0001
818 BREAST CANCER STAGE I 1 0.0001
819 JOINT SWELLING 13 0.0001
820 BLOOD CHOLESTEROL INCREASED 5 0.0001
821 BACTERIAL INFECTION 2 0.0001
822 BLISTER 6 0.0001
823 COLITIS 4 0.0001
824 INCORRECT DOSE ADMINISTERED 24 0.0001
825 RED BLOOD CELL COUNT DECREASED 3 0.0001
826 PRODUCTIVE COUGH 5 0.0001
827 MULTIPLE SCLEROSIS 5 0.0001
828 BALANCE DISORDER 9 0.0001
829 LOWER LIMB FRACTURE 2 0.0001
830 PRESCRIBED OVERDOSE 2 0.0001
831 BONE PAIN 6 0.0001
832 TACHYCARDIA 9 0.0001
833 BRAIN INJURY 1 0.0001
834 PRODUCT PHYSICAL ISSUE 2 0.0001
835 TASTE DISORDER 2 0.0001
836 BLINDNESS 4 0.0001
837 VISUAL IMPAIRMENT 12 0.0001
838 OFF LABEL USE 84 0.0001
839 UNDERDOSE 7 0.0001
840 DRUG-INDUCED LIVER INJURY 3 0.0001
841 SPEECH DISORDER 5 0.0001
842 AGITATION 7 0.0001
843 GAIT DISTURBANCE 18 0.0001
844 HYPOTHYROIDISM 3 0.0001
845 EATING DISORDER 2 0.0001
846 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 19 0.0001
847 LOSS OF CONSCIOUSNESS 12 0.0001
848 BODY HEIGHT DECREASED 1 0.0001
849 CONTUSION 9 0.0001
850 DRUG INTOLERANCE 9 0.0001
851 CONFUSIONAL STATE 15 0.0001
852 PRURITUS GENERALISED 2 0.0001
853 INCORRECT PRODUCT ADMINISTRATION DURATION 2 0.0001
854 DEVICE LEAKAGE 4 0.0001
855 OEDEMA 5 0.0001
856 CHRONIC KIDNEY DISEASE 7 0.0001
857 BLOOD GLUCOSE FLUCTUATION 1 0.0001
858 APPLICATION SITE PAIN 2 0.0001
859 HAEMATOCHEZIA 5 0.0001
860 GLOSSODYNIA 2 0.0001
861 PANCREATITIS ACUTE 2 0.0001
862 ACCIDENTAL EXPOSURE TO PRODUCT 9 0.0001
863 HYPOKALAEMIA 4 0.0001
864 DRY MOUTH 7 0.0001
865 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 4 0.0001
866 COVID-19 PNEUMONIA 1 0.0001
867 WHEEZING 5 0.0001
868 ATAXIA 1 0.0001
869 PRODUCT PRESCRIBING ERROR 2 0.0001
870 MOBILITY DECREASED 6 0.0001
871 BLOOD PRESSURE FLUCTUATION 2 0.0001
872 WHITE BLOOD CELL COUNT DECREASED 9 0.0001
873 NO ADVERSE EVENT 15 0.0001
874 DRUG EFFECT INCOMPLETE 3 0.0001
875 BURSITIS 1 0.0001
876 ILL-DEFINED DISORDER 5 0.0001
877 ACCIDENTAL OVERDOSE 3 0.0001
878 FALL 27 0.0001
879 ABASIA 2 0.0001
880 PNEUMONIA 26 0.0001
881 INTENTIONAL PRODUCT MISUSE 7 0.0001
882 SYNCOPE 8 0.0001
883 DYSPNOEA EXERTIONAL 3 0.0001
884 INTESTINAL OBSTRUCTION 3 0.0001
885 PRODUCT COMPLAINT 2 0.0001
886 HOSPITALISATION 12 0.0001
887 INFLAMMATION 4 0.0001
888 RASH GENERALISED 2 0.0001
889 ANKYLOSING SPONDYLITIS 1 0.0001
890 ASPARTATE AMINOTRANSFERASE INCREASED 4 0.0001
891 ASTHENIA 28 0.0001
892 EXTRA DOSE ADMINISTERED 3 0.0001
893 THROAT TIGHTNESS 2 0.0001
894 DYSKINESIA 3 0.0001
895 APPLICATION SITE RASH 1 0.0001
896 FEELING COLD 2 0.0001
897 COORDINATION ABNORMAL 1 0.0001
898 RENAL IMPAIRMENT 6 0.0001
899 BLOOD TEST ABNORMAL 1 0.0001
900 CEREBROVASCULAR ACCIDENT 12 0.0001
901 OSTEOARTHRITIS 3 0.0001
902 BRONCHOSPASM 1 0.0001
903 RECTAL HAEMORRHAGE 3 0.0001
904 DYSPHONIA 4 0.0001
905 LIVER DISORDER 3 0.0001
906 EPISTAXIS 5 0.0001
907 BONE LOSS 1 0.0001
908 APHASIA 2 0.0001
909 SUICIDE ATTEMPT 4 0.0001
910 PLATELET COUNT DECREASED 7 0.0001
911 DIABETES MELLITUS 5 0.0001
912 DRUG ADMINISTRATION ERROR 2 0.0001
913 ALANINE AMINOTRANSFERASE INCREASED 4 0.0001
914 RENAL DISORDER 3 0.0001
915 BASAL CELL CARCINOMA 1 0.0001
916 BONE DENSITY DECREASED 2 0.0001
917 CYANOSIS 1 0.0001
918 ARRHYTHMIA 3 0.0001
919 METABOLIC ACIDOSIS 2 0.0001
920 MOVEMENT DISORDER 2 0.0001
921 BACK DISORDER 1 0.0001
922 GENERAL PHYSICAL HEALTH DETERIORATION 7 0.0001
923 RENAL FAILURE 8 0.0001
924 EXPIRED PRODUCT ADMINISTERED 2 0.0001
925 AGGRESSION 3 0.0001
926 TYPE 2 DIABETES MELLITUS 2 0.0001
927 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 2 0.0001
928 DEVICE USE ERROR 2 0.0001
929 MUSCULOSKELETAL PAIN 3 0.0001
930 DRUG WITHDRAWAL SYNDROME 5 0.0001
931 HEART RATE DECREASED 2 0.0001
932 PANCREATITIS 3 0.0001
933 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
934 BRADYCARDIA 3 0.0001
935 HYPERGLYCAEMIA 2 0.0001
936 TREATMENT NONCOMPLIANCE 3 0.0001
937 DYSURIA 2 0.0001
938 NECK PAIN 3 0.0001
939 HALLUCINATION 4 0.0001
940 BLOOD SODIUM DECREASED 1 0.0001
941 BLOOD URINE PRESENT 1 0.0001
942 CHOKING 1 0.0001
943 ACTIVITIES OF DAILY LIVING IMPAIRED 1 0.0001
944 BLOOD PRESSURE ABNORMAL 1 0.0001
945 STOMATITIS 3 0.0000
946 PLEURAL EFFUSION 3 0.0000
947 ANGIOEDEMA 2 0.0000
948 BLOOD PRESSURE DECREASED 3 0.0000
949 HYPOTENSION 9 0.0000
950 APPLICATION SITE PRURITUS 1 0.0000
951 BLOOD GLUCOSE INCREASED 8 0.0000
952 NEUROPATHY PERIPHERAL 4 0.0000
953 HYPOGLYCAEMIA 2 0.0000
954 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
955 CARDIOVASCULAR DISORDER 1 0.0000
956 BREAST CANCER FEMALE 1 0.0000
957 BLOOD BILIRUBIN INCREASED 1 0.0000
958 TREATMENT FAILURE 3 0.0000
959 MEDICATION ERROR 2 0.0000
960 CONVULSION 2 0.0000
961 ANGINA PECTORIS 1 0.0000
962 ASCITES 1 0.0000
963 ACUTE MYOCARDIAL INFARCTION 1 0.0000
964 ACUTE KIDNEY INJURY 5 0.0000
965 OVERDOSE 7 0.0000
966 BREAST CANCER 3 0.0000
967 ANAEMIA 6 0.0000
968 NEUTROPENIA 4 0.0000
969 CEREBRAL HAEMORRHAGE 1 0.0000
970 SEPSIS 3 0.0000
971 DRUG DOSE OMISSION BY DEVICE 2 0.0000
972 ARTHRITIS 2 0.0000
973 DRUG ABUSE 2 0.0000
974 CARDIO-RESPIRATORY ARREST 1 0.0000
975 MYOCARDIAL INFARCTION 4 0.0000
976 CARDIAC DISORDER 2 0.0000
977 HAEMOGLOBIN DECREASED 2 0.0000
978 ARTHROPATHY 1 0.0000
979 CATARACT 1 0.0000
980 CARDIAC FAILURE 1 0.0000
981 CARDIAC FAILURE CONGESTIVE 1 0.0000
982 DRUG DEPENDENCE 2 0.0000
983 CARDIAC ARREST 1 0.0000
984 TOXICITY TO VARIOUS AGENTS 2 0.0000
985 ATRIAL FIBRILLATION 1 0.0000
986 DEATH 5 0.0000